Menopausal Hormone Therapy And Its Awareness In Women

Menopause results from cease in ovarian follicular function and marks the end of menstruation. Most women experience menopause between the ages of 40 and 58 years. Hormone replacement therapy (HRT) in the form of estrogen alone or combined estrogen and progesterone formulations has been widely used to treat menopausal symptoms to improve women’s quality of life, control their climacteric symptoms and prevent osteoporosis. This study aims to investigate the knowledge and awareness of women towards menopausal hormone replacement therapy and its role in the management of menopause. A cross-sectional observational study was carried out in female population above 18 years of age for 1.5 months. Data was collected using a prestructured online questionnaire using social media platforms. The questionnaire consisted of questions about demographics, menstruation status and about awareness regarding menopause and hormone replacement therapy including menopausal symptoms, HRT treatment options, side effects of HRT etc. 101 participants cooperated with the survey ranging from 18 years and above. 61.4% (n=101) were not in the perimenopausal or menopausal stage, 17.8% were perimenopausal, 7.9% were menopausal and 12.9% were not sure which group they belonged to. Only 18.8% felt well informed about perimenopause/menopause while 66.3% had some knowledge about it and 18.8% are not informed at all. 36.6% had heard of HRT whereas 53.5% had no knowledge about it. This survey demonstrated that the awareness of women about menopausal hormone therapy was not comprehensive and they should be educated more about menopause and use of HRT. Even though some women are aware of HRT as a treatment option; however, a lack of both proper information and positive attitude towards HRT use was noted.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-20
DOI
https://doi.org/10.5281/zenodo.13820255
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Menopausal Hormone Therapy And Its Awareness In Women

Zenodo (CERN European Organization for Nuclear Research)
Menopause: Health Impacts and Treatments
article

Menopausal Hormone Therapy And Its Awareness In Women

article en

Abstract

Menopause results from cease in ovarian follicular function and marks the end of menstruation. Most women experience menopause between the ages of 40 and 58 years. Hormone replacement therapy (HRT) in the form of estrogen alone or combined estrogen and progesterone formulations has been widely used to treat menopausal symptoms to improve women’s quality of life, control their climacteric symptoms and prevent osteoporosis. This study aims to investigate the knowledge and awareness of women towards menopausal hormone replacement therapy and its role in the management of menopause. A cross-sectional observational study was carried out in female population above 18 years of age for 1.5 months. Data was collected using a prestructured online questionnaire using social media platforms. The questionnaire consisted of questions about demographics, menstruation status and about awareness regarding menopause and hormone replacement therapy including menopausal symptoms, HRT treatment options, side effects of HRT etc. 101 participants cooperated with the survey ranging from 18 years and above. 61.4% (n=101) were not in the perimenopausal or menopausal stage, 17.8% were perimenopausal, 7.9% were menopausal and 12.9% were not sure which group they belonged to. Only 18.8% felt well informed about perimenopause/menopause while 66.3% had some knowledge about it and 18.8% are not informed at all. 36.6% had heard of HRT whereas 53.5% had no knowledge about it. This survey demonstrated that the awareness of women about menopausal hormone therapy was not comprehensive and they should be educated more about menopause and use of HRT. Even though some women are aware of HRT as a treatment option; however, a lack of both proper information and positive attitude towards HRT use was noted.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 48%
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.